UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported) December 8, 2008
-------------
FERO INDUSTRIES, INC.
(Name of Small Business issuer in its charter)
Colorado 000-53337 01-0884561
(State or other jurisdiction of (Commission File No.) (IRS Employer incorporation or organization) Identification Number)
17 Reeves Crescent, Red Deer, AB T4P 2Z4 Canada
(Address of principal executive offices)
(403 ) 827-7936
(Registrant’s telephone number)
-------------------------
Item 8 01. Other Events
On December 8, 2008 Fero Industries, Inc. (the “Registrant”) has entered into an Interim Agreement with Pyro Pharmaceuticals, Inc. of Los Angeles California. Pyro Pharmaceuticals, Inc. is engaged in the business of developing therapeutics against multi-drug resistant infectious microorganisms. A definitive agreement be entered into as soon as possible but no later than January 15, 2009, with Closing to occur on or before February 27, 2009 and will be subject to certain terms and conditions. The Definitive Agreement will provide for the exchange of each of the Company’s common stock, with Fero remaining as the parent entity and Pyro a wholly owned subsidiary.
A copy of the news release is included in this document as Exhibit 99.1
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
EXHIBITS
|
10.1 Interim Agreement Between Fero and Pyro |
|
99.1 December 8, 2008 News Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Fero Industries, Inc.
/s/Kyle Schlosser
CEO and Director
December 8, 2008
